NCO-PEG-Carmofur异氰酸酯聚乙二醇卡莫氟 NCO-PEG-Cytarabine异氰酸酯聚乙二醇盐酸阿糖胞苷 NCO-PEG-Mercaptopurine 异氰酸酯聚乙二醇巯嘌呤 NCO-PEG-AT-1438 异氰酸酯聚乙二醇磺巯嘌呤钠(溶癌呤) NCO-PEG-MTX异氰酸酯聚乙二醇甲氨蝶呤 NCO-PEG-Tomudex 异氰酸酯聚乙二醇拉泰曲克 NCO-PEG- Edatrexate(10-EDAM)...
兒童及青少年之晚期大細胞淋巴瘤:將中劑量MTX及大劑量cytarabine融入APO療法維持期之隨機試驗結果:一兒科癌症團體之phase Ⅲ試驗頁面尚無資料邱宗傑中華民國血液病學會&中華民國血液及骨髓移植學會中華民國血液病學會&中華民國血液及骨髓移植學會聯合會訊
伴有心功能不全的肿瘤病人不宜应用哪一个抗癌药? (3.0分) A. Doxorubicin(adriamycin, ADM) B. Methotrexate(MTX) C. Mercaptopurine(6-MP) D. Cytarabine(Ara-C) E. Cisplatin(DDP) 相关知识点: 试题来源: 解析 A.Doxorubicin ( adriamycin, ADM ) ...
Addition of cytarabine to HD-MTX improved complete response rate (46% vs. 18%) and 3-year OS (46% vs. 32%)18. Another IELSG phase 2 trial showed that patients treated with methotrexate-cytarabine plus thiotepa and rituximab had higher complete remission rate than those treated with ...
5.DNA多聚酶抑制药阿糖胞苷(cytarabine,Ara-C)影响DNA合成,也渗入到DNA中干扰其复制→细胞死亡。治疗成人急粒/单核白血病破荡戗凭癌箐薮虞叹与郫徕鳐枧梭咐衤沪竞裕蒙泵测垒潭怕抑摁藉娓耆冖弼邈祯串转颓胡考鲶楠灾苍任(二)直接影响DNA结构与功能的药物1.烷化剂(alkylatingagents)所含烷化基团与细胞的...
methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma... - 《Leukemia & Lymphoma》 被引量: 11发表: 2013年 R-HCVAD/R-MTX-AraC (R-HCVAD) Overcomes Risk Features Associated with Inferior Outcom...
Millot F, Suciu S, Philippe N, Children’s Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer et al (1993) Value of high dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster based protocol in increased-risk children with acute lymphatic le...
NCO-PEG-Cytarabine异氰酸酯聚乙二醇盐酸阿糖胞苷 NCO-PEG-Mercaptopurine 异氰酸酯聚乙二醇巯嘌呤 NCO-PEG-AT-1438 异氰酸酯聚乙二醇磺巯嘌呤钠(溶癌呤) NCO-PEG-MTX异氰酸酯聚乙二醇甲氨蝶呤 NCO-PEG-Tomudex 异氰酸酯聚乙二醇拉泰曲克 NCO-PEG- Edatrexate(10-EDAM) 异氰酸酯聚乙二醇依达曲沙...
CytarabineThe article describes the case of a woman who developed various toxicities while receiving intrathecal cytarabine for acute promyelocytic leukemia.Reactions Weekly
CytarabinePresents a study which examined the effectiveness of cytarabine, a pyrimidine nucleotides in leukemia treatment. Pharmacology and biological properties; Clinical applications; Toxicity.Kremer, William BAnnals of Internal Medicine